Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation
申请人:UNIVERSITAT BERN
公开号:US10300048B2
公开(公告)日:2019-05-28
The invention relates to a compound comprising the following general formula (1) for use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation: (1) wherein each of R1, R2 and R3 are selected independently from each other from alkyl, alkoxy, alkenyl, alkynyl, cycloalkyl, aryl, heterocycle or heteroaryl.
本发明涉及一种包含以下通式(1)的化合物,用于治疗精神或神经系统疾病和炎症,特别是神经炎症:(1)其中 R1、R2 和 R3 各自独立地选自烷基、烷氧基、烯基、炔基、环烷基、芳基、杂环或杂芳基。